Lupin stated that its US-based unit has inked a pact with Exeltis Inc to promote Solosec, a drug used to treat bacterial vaginosis in women.
As part of the tie up, Exeltis will promote Solosec along with its existing line of women's health products.
Solosec is indicated for the treatment of bacterial vaginosis in adult women and trichomoniasis in adults, a common non-viral, curable sexually transmitted infection in the US.
''This partnership will expand the reach of Solosec, allowing more healthcare providers to be aware of its benefits, and increase access for adult women suffering with bacterial vaginosis and adults with trichomoniasis,'' stated Lupin CEO Vinita Gupta.
Mumbai Weather Update, Feb 15: City Wakes Up To Severe Air Quality, AQI Crosses 200 In Several Areas Including BKC & Kurla
IND vs PAK T20 World Cup: What Happens If Colombo Match Is Washed Out? Rules & Implications Explained
US: 22-Year-Old IIT Madras Alumnus Saketh Sreenivasaiah Found Dead 6 Days After Going Missing In California
O'Romeo Box Office Collection Day 2: Shahid Kapoor & Triptii Dimri's Film Earns ₹12.25 Crore, Records 45% Jump On Valentine's Day
(With inputs from PTI)
